Researchers from Seattle Children’s and Novartis shed light on developmental brain disorders that lead to intractable epilepsy.

The culture of volunteerism is a fundamental part of the Novartis corporate ethos. Here’s a snapshot of our efforts over the years.

For patients with lung cancer, biomarker testing may be an option.

Raising a child with a rare disease can feel overwhelming and isolating, but many parents end up being extremely proud of their children’s achievements.

On Friday nights, Juan Pedro García Hernández goes dancing – but for rest of the time he’s taking care of his mother.

Patients with glaucoma, which affects 60 million people worldwide, can lose up to 40 percent of their sight before they begin to notice any change in vision.

Jennifer Leeds offers a behind-the-scenes look at the consortia forming to address COVID-19.

Functional genomics study reveals a potential approach for tackling glioblastoma, pancreatic cancer and other tumors.

For over 60 years Novartis has been committed to helping people with cardiovascular disease and we remain steadfast in that commitment to this day.

Novartis researchers have discovered a compound that is showing promise against three parasites that cause three neglected diseases.